153 related articles for article (PubMed ID: 28126585)
1. Homozygous familial hypercholesterolemia: Summarized case reports.
Widhalm K; Benke IM; Fritz M; Geiger H; Helk O; Fritsch M; Hoermann G; Kostner G
Atherosclerosis; 2017 Feb; 257():86-89. PubMed ID: 28126585
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome in 53 patients with homozygous familial hypercholesterolaemia in a single centre in France.
Bruckert E; Kalmykova O; Bittar R; Carreau V; Béliard S; Saheb S; Rosenbaum D; Bonnefont-Rousselot D; Thomas D; Emery C; Khoshnood B; Carrié A
Atherosclerosis; 2017 Feb; 257():130-137. PubMed ID: 28131047
[TBL] [Abstract][Full Text] [Related]
3. Homozygous familial hypercholesterolemia in childhood: Genotype-phenotype description, established therapies and perspectives.
Sanna C; Stéphenne X; Revencu N; Smets F; Sassolas A; Di Filippo M; Descamps OS; Sokal EM
Atherosclerosis; 2016 Apr; 247():97-104. PubMed ID: 26894473
[TBL] [Abstract][Full Text] [Related]
4. A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry).
Kayikcioglu M; Tokgozoglu L; Yilmaz M; Kaynar L; Aktan M; Durmuş RB; Gokce C; Temizhan A; Ozcebe OI; Akyol TK; Okutan H; Sag S; Gul OO; Salcioglu Z; Yenercag M; Altunkeser BB; Kuku I; Yasar HY; Kurtoglu E; Kose MD; Demircioglu S; Pekkolay Z; Ilhan O
Atherosclerosis; 2018 Mar; 270():42-48. PubMed ID: 29407887
[TBL] [Abstract][Full Text] [Related]
5. Managing homozygous familial hypercholesterolaemia from cradle to grave.
Thompson GR
Atheroscler Suppl; 2015 May; 18():16-20. PubMed ID: 25936299
[TBL] [Abstract][Full Text] [Related]
6. Homozygous familial hypercholesterolaemia in Vietnam: Case series, genetics and cascade testing of families.
Truong TH; Kim NT; Nguyen MNT; Pang J; Hooper AJ; Watts GF; Do DL
Atherosclerosis; 2018 Oct; 277():392-398. PubMed ID: 30270076
[TBL] [Abstract][Full Text] [Related]
7. HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom.
France M; Rees A; Datta D; Thompson G; Capps N; Ferns G; Ramaswami U; Seed M; Neely D; Cramb R; Shoulders C; Barbir M; Pottle A; Eatough R; Martin S; Bayly G; Simpson B; Halcox J; Edwards R; Main L; Payne J; Soran H;
Atherosclerosis; 2016 Dec; 255():128-139. PubMed ID: 27839699
[TBL] [Abstract][Full Text] [Related]
8. Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment.
Raal FJ; Santos RD
Atherosclerosis; 2012 Aug; 223(2):262-8. PubMed ID: 22398274
[TBL] [Abstract][Full Text] [Related]
9. High serum triglyceride concentrations in patients with homozygous familial hypercholesterolemia attenuate the efficacy of lipoprotein apheresis by dextran sulfate adsorption.
Drouin-Chartier JP; Tremblay AJ; Bergeron J; Lamarche B; Couture P
Atherosclerosis; 2018 Mar; 270():26-32. PubMed ID: 29407885
[TBL] [Abstract][Full Text] [Related]
10. Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia-target attainment requires further increase of intensity.
Klaus G; Taylan C; Büscher R; Schmitt CP; Pape L; Oh J; Driemeyer J; Galiano M; König J; Schürfeld C; Spitthöver R; Schaefer JR; Weber LT; Heibges A; Klingel R
Pediatr Nephrol; 2018 Jul; 33(7):1199-1208. PubMed ID: 29502162
[TBL] [Abstract][Full Text] [Related]
11. First case report of familial hypercholesterolemia in an Omani family due to novel mutation in the low-density lipoprotein receptor gene.
Al-Hinai AT; Al-Abri A; Al-Dhuhli H; Al-Waili K; Al-Sabti H; Al-Yaarubi S; Al-Hashmi K; Banerjee Y; Al-Zakwani I; Al-Rasadi K
Angiology; 2013 May; 64(4):287-92. PubMed ID: 23162007
[TBL] [Abstract][Full Text] [Related]
12. How can we improve the prognosis of patients with homozygous familial hypercholesterolemia?
Harada-Shiba M
Atherosclerosis; 2024 Jun; 393():117551. PubMed ID: 38658251
[No Abstract] [Full Text] [Related]
13. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society.
Cuchel M; Bruckert E; Ginsberg HN; Raal FJ; Santos RD; Hegele RA; Kuivenhoven JA; Nordestgaard BG; Descamps OS; Steinhagen-Thiessen E; Tybjærg-Hansen A; Watts GF; Averna M; Boileau C; Borén J; Catapano AL; Defesche JC; Hovingh GK; Humphries SE; Kovanen PT; Masana L; Pajukanta P; Parhofer KG; Ray KK; Stalenhoef AF; Stroes E; Taskinen MR; Wiegman A; Wiklund O; Chapman MJ;
Eur Heart J; 2014 Aug; 35(32):2146-57. PubMed ID: 25053660
[TBL] [Abstract][Full Text] [Related]
14. Treatment of homozygous familial hypercholesterolaemia in paediatric patients: A monocentric experience.
Buonuomo PS; Macchiaiolo M; Leone G; Valente P; Mastrogiorgio G; Gnazzo M; Rana I; Gonfiantini MV; Gagliardi MG; Romano F; Bartuli A
Eur J Prev Cardiol; 2018 Jul; 25(10):1098-1105. PubMed ID: 29785886
[TBL] [Abstract][Full Text] [Related]
15. Apheresis in homozygous familial hypercholesterolemia: the results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia.
Græsdal A; Bogsrud MP; Holven KB; Nenseter MS; Narverud I; Langslet G; Brekke M; Retterstøl K; Arnesen KE; Ose L
J Clin Lipidol; 2012; 6(4):331-9. PubMed ID: 22836070
[TBL] [Abstract][Full Text] [Related]
16. The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia - a post-hoc analysis of a Phase 3, single-arm, open-label trial.
Stefanutti C; Blom DJ; Averna MR; Meagher EA; Theron Hd; Marais AD; Hegele RA; Sirtori CR; Shah PK; Gaudet D; Vigna GB; Sachais BS; Di Giacomo S; du Plessis AM; Bloedon LT; Balser J; Rader DJ; Cuchel M;
Atherosclerosis; 2015 Jun; 240(2):408-14. PubMed ID: 25897792
[TBL] [Abstract][Full Text] [Related]
17. Phenotype diversity among patients with homozygous familial hypercholesterolemia: A cohort study.
Raal FJ; Sjouke B; Hovingh GK; Isaac BF
Atherosclerosis; 2016 May; 248():238-44. PubMed ID: 27017151
[TBL] [Abstract][Full Text] [Related]
18. The Low-Density Lipoprotein Receptor Genotype Is a Significant Determinant of the Rebound in Low-Density Lipoprotein Cholesterol Concentration After Lipoprotein Apheresis Among Patients With Homozygous Familial Hypercholesterolemia.
Drouin-Chartier JP; Tremblay AJ; Bergeron J; Lamarche B; Couture P
Circulation; 2017 Aug; 136(9):880-882. PubMed ID: 28847800
[No Abstract] [Full Text] [Related]
19. Pregnancy in homozygous familial hypercholesterolemia--Importance of LDL-apheresis.
Blaha M; Lanska M; Blaha V; Boudys L; Zak P
Atheroscler Suppl; 2015 May; 18():134-9. PubMed ID: 25936317
[TBL] [Abstract][Full Text] [Related]
20. A cross-national investigation of cardiovascular survival in homozygous familial hypercholesterolemia: The Sino-Roman Study.
Stefanutti C; Pang J; Di Giacomo S; Wu X; Wang X; Morozzi C; Watts GF; Lin J
J Clin Lipidol; 2019; 13(4):608-617. PubMed ID: 31255589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
